Jeffrey I. Greenstein

759 total citations
30 papers, 566 citations indexed

About

Jeffrey I. Greenstein is a scholar working on Pathology and Forensic Medicine, Immunology and Molecular Biology. According to data from OpenAlex, Jeffrey I. Greenstein has authored 30 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 9 papers in Immunology and 8 papers in Molecular Biology. Recurrent topics in Jeffrey I. Greenstein's work include Multiple Sclerosis Research Studies (10 papers), Peripheral Neuropathies and Disorders (4 papers) and Virology and Viral Diseases (4 papers). Jeffrey I. Greenstein is often cited by papers focused on Multiple Sclerosis Research Studies (10 papers), Peripheral Neuropathies and Disorders (4 papers) and Virology and Viral Diseases (4 papers). Jeffrey I. Greenstein collaborates with scholars based in United States. Jeffrey I. Greenstein's co-authors include Henry F. McFarland, Dimitris P. Agamanolis, Fred Lublin, Nizar Souayah, Dale E. McFarlin, Timothy J. Cunningham, Charles R. Smith, Martin W. Adler, Gary Birnbaum and Lihua Yao and has published in prestigious journals such as The Journal of Immunology, Neurology and Annals of the New York Academy of Sciences.

In The Last Decade

Jeffrey I. Greenstein

29 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey I. Greenstein United States 13 212 137 134 113 94 30 566
Federica Esposito Italy 17 373 1.8× 169 1.2× 212 1.6× 135 1.2× 72 0.8× 68 810
Mathias Granqvist Sweden 8 193 0.9× 92 0.7× 100 0.7× 196 1.7× 76 0.8× 13 503
A. Garcı́a-Merino Spain 11 156 0.7× 105 0.8× 82 0.6× 155 1.4× 49 0.5× 18 480
M. Rieks Germany 7 141 0.7× 102 0.7× 113 0.8× 47 0.4× 64 0.7× 9 453
Anne Willing Germany 11 191 0.9× 257 1.9× 118 0.9× 78 0.7× 57 0.6× 16 556
Dongwei Wang China 10 93 0.4× 188 1.4× 145 1.1× 225 2.0× 47 0.5× 23 692
Melody Chao United Kingdom 11 289 1.4× 211 1.5× 301 2.2× 41 0.4× 53 0.6× 18 763
O Sabouraud France 10 322 1.5× 74 0.5× 72 0.5× 204 1.8× 150 1.6× 35 544
Bhim Singhal India 14 111 0.5× 49 0.4× 236 1.8× 147 1.3× 21 0.2× 21 506
Kristine D. Baerwald United States 7 115 0.5× 193 1.4× 172 1.3× 35 0.3× 100 1.1× 9 578

Countries citing papers authored by Jeffrey I. Greenstein

Since Specialization
Citations

This map shows the geographic impact of Jeffrey I. Greenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey I. Greenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey I. Greenstein more than expected).

Fields of papers citing papers by Jeffrey I. Greenstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey I. Greenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey I. Greenstein. The network helps show where Jeffrey I. Greenstein may publish in the future.

Co-authorship network of co-authors of Jeffrey I. Greenstein

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey I. Greenstein. A scholar is included among the top collaborators of Jeffrey I. Greenstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey I. Greenstein. Jeffrey I. Greenstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cunningham, Timothy J., Jeffrey I. Greenstein, Lihua Yao, Itzhak Fischer, & Theresa Connors. (2018). Heptamer Peptide Disassembles Native Amyloid in Human Plasma Through Heat Shock Protein 70. Rejuvenation Research. 21(6). 527–534. 2 indexed citations
3.
Cunningham, Timothy J., et al.. (2014). Anti-Inflammatory Peptide Regulates the Supply of Heat Shock Protein 70 Monomers: Implications for Aging and Age-Related Disease. Rejuvenation Research. 18(2). 136–144. 14 indexed citations
4.
Greenstein, Jeffrey I. & Timothy J. Cunningham. (2014). Neuroprotective, Anti-Inflammatory and Immune Tolerizing Properties of Peptides Derived from Diffusion Survival Evasion Protein (DSEP)/Dermcidin. (P1.175). Neurology. 82(10_supplement). 1 indexed citations
5.
Cunningham, Timothy J., Jeffrey I. Greenstein, & Lihua Yao. (2009). Uncompetitive Phospholipase A2 Inhibition by CHEC Sequences Including Oral Treatment of Experimental Autoimmune Myeloencephalitis. 2(1). 1–7. 5 indexed citations
6.
Greenstein, Jeffrey I.. (2007). Current concepts of the cellular and molecular pathophysiology of multiple sclerosis. Developmental Neurobiology. 67(9). 1248–1265. 30 indexed citations
7.
Cunningham, Timothy J., et al.. (2006). Secreted phospholipase A2 activity in experimental autoimmune encephalomyelitis and multiple sclerosis.. Journal of Neuroinflammation. 3(1). 26–26. 45 indexed citations
8.
Souayah, Nizar & Jeffrey I. Greenstein. (2005). Insights into neurologic localization by Rhazes, a medieval Islamic physician. Neurology. 65(1). 125–128. 28 indexed citations
9.
Greenstein, Jeffrey I.. (2002). Problems in Clinical Trial Design in Multiple Sclerosis. International Journal of MS Care. 4(3). 125–138. 3 indexed citations
10.
Stuart, William H., et al.. (2000). Registry of Multiple Sclerosis Treatment and Care (MSTRAC) Patient and Physician Characteristics. International Journal of MS Care. 2(4). 25–36. 3 indexed citations
11.
Legido, Agustín, Martin W. Adler, E B Geller, et al.. (1995). Cholecystokinin potentiates morphine anticonvulsant action through both CCK-A and CCK-B receptors. Neuropeptides. 28(2). 107–113. 12 indexed citations
12.
Knobler, Robert L., Jeffrey I. Greenstein, K. P. Johnson, et al.. (1993). Systemic Recombinant Human Interferon-β Treatment of Relapsing–Remitting Multiple Sclerosis: Pilot Study Analysis and Six-Year Follow-Up. Journal of Interferon Research. 13(5). 333–340. 92 indexed citations
13.
Bell, Jeffrey A., Martin W. Adler, Jeffrey I. Greenstein, & Lee‐Yuan Liu‐Chen. (1993). Identification and characterization of [125I] arginine vasopressin binding sites on human peripheral blood mononuclear cells. Life Sciences. 52(1). 95–105. 25 indexed citations
14.
Bell, Jeffrey A., Martin W. Adler, & Jeffrey I. Greenstein. (1992). The effect of arginine vasopressin on the autologous mixed lymphocyte reaction. International Journal of Immunopharmacology. 14(1). 93–103. 13 indexed citations
15.
Greenstein, Jeffrey I., et al.. (1989). Studies on protein methyltransferase in human cerebrospinal fluid. Journal of Molecular Neuroscience. 1(3). 151–157. 5 indexed citations
16.
Greenstein, Jeffrey I., Henry F. McFarland, & J R Richert. (1986). Characterization of antigen-specific T cells in multiple sclerosis twins with elevated proliferative responses to measles virus.. The Journal of Immunology. 137(2). 546–550. 7 indexed citations
17.
Richert, John R., et al.. (1984). Characterization of Cerebrospinal Fluid Lymphocytes in Multiple Sclerosisa. Annals of the New York Academy of Sciences. 436(1). 151–162. 2 indexed citations
18.
Greenstein, Jeffrey I. & Henry F. McFarland. (1983). Response of human lymphocytes to measles virus after natural infection. Infection and Immunity. 40(1). 198–204. 21 indexed citations
19.
Greenstein, Jeffrey I. & Henry F. McFarland. (1982). Immunological Responses to Viruses in Multiple Sclerosis: Cell-mediated Immunity. 2(2). 371–383. 10 indexed citations
20.
Greenstein, Jeffrey I., et al.. (1953). Use of ACTH and cortisone in Guillain-Barré syndrome.. PubMed. 36(12). 718–20. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026